Checkpoint inhibitor associated autoimmune diabetes (CIADM) is distinct from type 1 diabetes

Title
Checkpoint inhibitor associated autoimmune diabetes (CIADM) is distinct from type 1 diabetes
Authors
Keywords
-
Journal
Publisher
The Endocrine Society
Online
2019-07-02
DOI
10.1210/jc.2019-00423

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started